More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-20 of 20 results

  • www.reblozylpro.com
REBLOZYL offers 3 dose levels to optimize patient response. Learn how to titrate REBLOZYL to maximize clinical benefit... Discover how Reblozyl® can treat anemia in LR-MDS-RS patients with ring sideroblasts. See safety information, including..
Relevance: 83.9807
  • www.connect2bms.com
At Bristol Myers Squibb, we're committed to supporting our customers through dedicated Account teams and patient-focused educational resources designed for payers, organized customers, formulary decision-makers, and professionals involved in..
Relevance: 83.9807
  • www.bmsehr.com
We know EHR systems are a crucial part of your daily routine. BMS has developed materials designed to put information you need about BMS medicines where you need it-in your workflow... BMS has developed resources to help integrate key information..
Relevance: 83.105675
  • bmsaccesssupportvirtual.com
  • 2
Bristol Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement support services... This information is intended for U.S. healthcare professionals and/or healthcare professionals..
Relevance: 83.105675
  • www.bmsmedicaleducation.com
  • 2
Your use of this information is subject to the terms and conditions of our Legal Notice and Privacy Policy. This site is intended for healthcare professionals and is for informational purposes only...
Relevance: 82.71689
  • www.immunooncology.com
  • 1
At Bristol Myers Squibb, we're leading the way in Immuno-Oncology research. I-O research aims to offer renewed hope to patients with advanced cancers. Learn more... Imagine your body as a garden, where the soil is your immune system. When you're..
Relevance: 82.71689
  • bmspatientresources.com
  • 1
We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. In 2020, we invested $11.1 billion in R&D, which included the discovery and development of new medicines...
Relevance: 82.71689
  • www.learnabouttyk2.com
  • 1
At BMS, we are committed to helping patients prevail over serious immune-related diseases such as psoriasis. We're excited about our innovative research on the TYK2 pathway and the role it may play in immunology... Learn more about the tyrosine..
Relevance: 82.71689
  • www.sprycel-hcp.com
SPRYCEL is associated with the following warnings and precautions: myelosuppression, bleeding-related events, fluid retention, cardiovascular toxicity, pulmonary arterial hypertension, QT prolongation, severe dermatologic reactions, tumor lysis..
Relevance: 82.710434
  • www.evotazhcp.com
EVOTAZ and REYATAZ are registered trademarks of Bristol-Myers Squibb Company. All other trademarks are the property of their respective owners and not of Bristol-Myers Squibb Company... Learn about EVOTAZ® (atazanavir/cobicistat) for treatment-naïve..
Relevance: 82.710434
  • www.targetedproteindegraders.com
BMS is leading in targeted protein degradation by taking two approaches: ligase modulation and ligand-directed degradation... Both strategies degrade proteins that contribute to disease progression. 1-6 The exact effect of each cereblon E3 ligase.....
Relevance: 82.710434
  • www.opd.bmssafetytools.com
For safety information about OPDIVO® (nivolumab) or OPDIVO® in combination with YERVOY® (ipilimumab), please refer to the Local Prescribing Information which can found in the Product Pack...
Relevance: 82.239944
  • www.realconnections.com
  • 1
  • 1
REAL Connections is a simple communication program to help engage cancer patients... The REAL Connections program provides practical, evidence-based tools for care teams and patients with cancer... Aims to optimize current education efforts through..
Relevance: 82.239944
  • www.car-t-academy.com
Learn about the role of bridging therapy, its coordination and delivery, and various bridging therapy options; the purpose of lymphodepleting (LD) chemotherapy and its impact on the immune system; the LD regimens used in CAR T cell trials; the..
Relevance: 82.239944
  • www.connectregistries.com
The Connect® Registry Team would like to thank all the patients and their caregivers who have contributed so far to the Connect® Registries. Because of you, we have been able to collect information on Myeloid diseases and Multiple Myeloma (MM)...
Relevance: 82.239944
  • www.bms.com
  • 3
  • 6
  • 32
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases...
Relevance: 38.645763
  • www.connect2bms.com
At Bristol Myers Squibb, we're committed to supporting our customers through dedicated Account teams and patient-focused educational resources designed for payers, organized customers, formulary decision-makers, and professionals involved in..
Relevance: 37.615093
  • www.sprycel.com
SPRYCEL®, the SPRYCEL logo, and Access Support® are registered trademarks of Bristol-Myers Squibb Company... SPRYCEL may help to inhibit BCR-ABL. SPRYCEL works by helping to reduce the number of damaged white blood cells in your body. This reduction..
Relevance: 34.31686
  • www.detect-afib.com
AFib may be difficult to detect in some patients, such as those with asymptomatic or paroxysmal AFib. Remote monitoring with FDA-cleared devices can help detect irregularities, such as AFib, beyond a pulse check. Early detection may be key to a..
Relevance: 34.161354
  • www.empliciti.com
  • 2
EMPLICITI®, the related logo, and Access Support® are registered trademarks of Bristol-Myers Squibb Company. POMALYST®, POMALYST REMS®, and REVLIMID® are registered trademarks of Celgene Corporation, a Bristol Myers Squibb company... EMPLICITI®..
Relevance: 34.161354